Status: Finalised First registered on: 30/06/2015
Last updated on: 27/02/2017
1. Study identification
EU PAS Register NumberEUPAS10129
Official titlePrevalence and Incidence of Problematic Prescription Opioid Use and Abuse in the United Kingdom and Germany
Study title acronymOXY9504
Study typeObservational study
Brief description of the study
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsIMS Health
Department/Research groupReal World Evidence Solutions
Organisation/affiliationIMS Health
Website/Homepagehttp://www.imshealth.com
Details of (Primary) lead investigator
Title Dr
Last name Kim
First name Joseph
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)

Countries in which this study is being conducted
International study

Germany
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed11/11/201302/12/2013
Start date of data collection11/03/201408/04/2014
Start date of data analysis25/05/2015
Date of interim report, if expected
Date of final study report25/05/201627/06/2016
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesMundipharma Research Ltd100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Andrew
First name Cooper
Address line 1Mundipharma Research Ltd
Address line 2 
Address line 3 
CityCambridge 
Postcode 
CountryUnited Kingdom
Phone number (incl. country code)441223397003 
Alternative phone number 
Fax number (incl. country code) 
Email address andrew.cooper@mundipharma-rd.eu
Public Enquiries
Title Dr 
Last name Andrew 
First name Cooper 
Address line 1Mundipharma Research 
Address line 2 
Address line 3 
CityCambridge 
Postcode 
CountryUnited Kingdom 
Phone number (incl. country code)441223397003 
Alternative phone number 
Fax number (incl. country code) 
Email address andrew.cooper@mundipharma-rd.eu 
Top